Pew Comments on Generic Drug Competition at FDA Public Meeting

Pew Comments on Generic Drug Competition at FDA Public Meeting

On Sept. 18, The Pew Charitable Trusts’ drug spending research initiative submitted comments to the Food and Drug Administration in response to its public meeting, “Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access.” Pew discussed ways to build on the success of the Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Act, such as mitigating unintended barriers to competition while balancing the need to encourage innovation and protect safety and quality.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.